Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Oral contraceptive pills: A risk factor for retinal vascular occlusion in in-vitro fertilization patients.

Aggarwal RS, Mishra VV, Aggarwal SV.

J Hum Reprod Sci. 2013 Jan;6(1):79-81. doi: 10.4103/0974-1208.112389.

PMID:
23869159
[PubMed]
Free PMC Article
2.

Central retinal vein occlusion in young women: rare cases with oral contraceptive pills as a risk factor.

Thapa R, Paudyal G.

Nepal Med Coll J. 2009 Sep;11(3):209-11.

PMID:
20334075
[PubMed - indexed for MEDLINE]
3.

Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.

Ding X, Li J, Hu X, Yu S, Pan J, Tang S.

Retina. 2011 May;31(5):838-45. doi: 10.1097/IAE.0b013e3181f4420d.

PMID:
21293319
[PubMed - indexed for MEDLINE]
4.

Systemic diseases associated with various types of retinal vein occlusion.

Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P.

Am J Ophthalmol. 2001 Jan;131(1):61-77.

PMID:
11162981
[PubMed - indexed for MEDLINE]
5.

[Treatment modalities in central retinal vein occlusion].

Masoud M, Siman-Tov S, Ibrahim A, Pikkel J.

Harefuah. 2010 Apr;149(4):245-50, 261, 260. Review. Hebrew.

PMID:
20812500
[PubMed - indexed for MEDLINE]
6.

Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.

Mitry D, Bunce C, Charteris D.

Cochrane Database Syst Rev. 2013 Jan 31;1:CD009510. doi: 10.1002/14651858.CD009510.pub2. Review.

PMID:
23440840
[PubMed - indexed for MEDLINE]
7.

[The eye and hormones: vascular disorders associated with combined oral contraceptives and pregnancy].

Villatte-cathelineau B.

Contracept Fertil Sex (Paris). 1985 Jan;13(1 Suppl):147-52. French.

PMID:
12280201
[PubMed - indexed for MEDLINE]
8.

Adverse events associated with intraocular injections of bevacizumab in eyes with neovascular glaucoma.

Higashide T, Murotani E, Saito Y, Ohkubo S, Sugiyama K.

Graefes Arch Clin Exp Ophthalmol. 2012 Apr;250(4):603-10. doi: 10.1007/s00417-011-1865-8. Epub 2011 Nov 25.

PMID:
22116499
[PubMed - indexed for MEDLINE]
9.

Unilateral macular edema with central retinal vein occlusion in systemic lupus erythematosus: a case report.

Noma H, Shimizu H, Mimura T.

Clin Ophthalmol. 2013;7:865-7. doi: 10.2147/OPTH.S44341. Epub 2013 May 9.

PMID:
23690676
[PubMed]
Free PMC Article
10.

Potential anti-vascular endothelial growth factor therapies for central retinal vein occlusion.

Figueroa MS, Contreras I.

Drugs. 2012 Nov 12;72(16):2063-71. doi: 10.2165/11640820-000000000-00000.

PMID:
23061805
[PubMed - indexed for MEDLINE]
11.

[Aging and retinal vascular diseases].

Takagi H.

Nihon Ganka Gakkai Zasshi. 2007 Mar;111(3):207-30; discussion 231. Review. Japanese.

PMID:
17402563
[PubMed - indexed for MEDLINE]
12.

Comparison between intravitreal bevacizumab and triamcinolone for macular edema secondary to branch retinal vein occlusion.

Kim JY, Park SP.

Korean J Ophthalmol. 2009 Dec;23(4):259-65. doi: 10.3341/kjo.2009.23.4.259. Epub 2009 Dec 4.

PMID:
20046685
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion.

CekiƧ O, Chang S, Tseng JJ, Barile GR, Weissman H, Del Priore LV, Schiff WM, Weiss M, Klancnik JM Jr.

Retina. 2005 Oct-Nov;25(7):846-50.

PMID:
16205562
[PubMed - indexed for MEDLINE]
14.

Retinal vein thrombosis: pathogenesis and management.

Rehak M, Wiedemann P.

J Thromb Haemost. 2010 Sep;8(9):1886-94. doi: 10.1111/j.1538-7836.2010.03909.x. Review.

PMID:
20492457
[PubMed - indexed for MEDLINE]
15.

Prevalent misconceptions about acute retinal vascular occlusive disorders.

Hayreh SS.

Prog Retin Eye Res. 2005 Jul;24(4):493-519. Review.

PMID:
15845346
[PubMed - indexed for MEDLINE]
16.

Aqueous vascular endothelial growth factor levels are associated with serous macular detachment secondary to branch retinal vein occlusion.

Park SP, Ahn JK, Mun GH.

Retina. 2010 Feb;30(2):281-6. doi: 10.1097/IAE.0b013e3181b9f153.

PMID:
19881397
[PubMed - indexed for MEDLINE]
17.

Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10.

Scott IU, VanVeldhuisen PC, Oden NL, Ip MS, Blodi BA, Hartnett ME, Cohen G; Standard Care versus COrticosteroid for REtinal Vein Occlusion Study Investigator Group.

Ophthalmology. 2011 Feb;118(2):345-52. doi: 10.1016/j.ophtha.2010.06.034.

PMID:
20926135
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Steroids and macular edema from retinal vein occlusion.

Glacet-Bernard A, Coscas G, Zourdani A, Soubrane G, Souied EH.

Eur J Ophthalmol. 2011;21 Suppl 6:S37-44. doi: 10.5301/EJO.2010.6053. Review.

PMID:
23264327
[PubMed - indexed for MEDLINE]
19.

Early change of central macular thickness after intravitreous triamcinolone or bevacizumab in diabetic macular edema or retinal vein occlusion.

Sonoda Y, Arimura N, Shimura M, Sakamoto T.

Retina. 2011 Feb;31(2):290-7. doi: 10.1097/IAE.0b013e3181eef070.

PMID:
21102366
[PubMed - indexed for MEDLINE]
20.

Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.

Mayer WJ, Remy M, Wolf A, Kook D, Kampik A, Ulbig M, Reznicek L, Haritoglou C.

Ophthalmologica. 2012;228(2):110-6. doi: 10.1159/000338732. Epub 2012 Jun 23.

PMID:
22739239
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk